跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Atopitar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Atopitar
Approved
STANDARD
Atopitar
Geofman Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5a708a76a4b1afa4
Company
Geofman Pharmaceuticals
Type
Standard
Approval Details
Approval Id
5a708a76a4b1afa4
Drug Approval Philippines Name
Atopitar
Product Name
Atopitar
Registration Number
DRP-2623
Brand Name
Atopitar
Generic Name
Atorvastatin (as calcium)
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Geofman Pharmaceuticals
Importer
Amson Pharmaceuticals
Distributor
Amson Pharmaceuticals
Issuance Date
28 August 2024
Expiry Date
14 October 2029
Pharmacologic Category
Antihyperlipidemic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5a708a76a4b1afa4
Type
Standard
Back to Philippines FDA Approvals